Hypersensitivity pneumonitis: difficulties of diagnosis and occupational pathological aspects

Hypersensitivity pneumonitis (HP) is an interstitial lung disease characterized by an immunological reaction of the lung parenchyma in response to certain antigens in a susceptible individual. According to the literature, the prevalence of HP is 1–4 cases per 100 thousand population. Identifying HP is a complex task and requires an integrated approach with the participation of different specialists, since currently there is no "gold standard" for its diagnosis. A clinical observation of a patient with HP that developed against the background of his professional activity is presented. Incomplete taking of the patient's medical history and insufficient consideration of the possible influence of work environment factors on the onset of the disease led to a delay in getting a correct diagnosis and prescribing appropriate treatment.

Contributions:
Pavlyukova M.V. — research concept and design, data collection and processing, text writing, editing;
Tikhomirova O.A. — data collection and processing, editing;
Frangu R.K. — data collection and processing, editing;
Stafeev A.N. — research concept and design, text writing, editing;
Mirzakhamidova S.S. — research concept and design, data collection and processing, editing;
Neklyudova G.V. — concept and design of research, editing;
Rachina S.A. — research concept and design, text writing, editing;
Avdeev S.N. — research concept and design, text writing, editing.

Funding. The study had no funding.

Conflict of interest. The authors declare no conflict of interest.

Received: 27.02.2025 / Accepted: 01.04.2025 / Published: 08.05.2025

1. Kadura S., Raghu G. Hypersensitivity pneumonitis: Principles in diagnosis and management. Respirology. 2023; 28(7): 599–602. https://doi.org/10.1111/resp.14514

2. Chandra D., Cherian S.V. Hypersensitivity Pneumonitis. 202. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. PMID: 29763093

3. Avdeev S.N. Hypersensitivity pneumonitis. Pulmonologiya. 2021; 31(1): 88–99 https://doi.org/10.18093/0869-0189-2021-31-1-88-99 (in Russian).

4. Avdeev S.N., Aisanov Z.R., Vizel A.A., Demko I.V., Ilkovich M.M., Kiniaikin M.F., Leshсhenko I.V., Orlova G.P., Samsonova M.V., Titova O.N., Trushenko N.V., Trofimenko I.N., Tyurin I.E., Fedotov V.D., Chernyaev A.L., Chernyak B.A., Chikina S.Yu., Shmelev E.I. Federal clinical guidelines on diagnosis and treatment of hypersensitivity pneumonitis. Pulmonologiya. 2025; 35(1): 16–41. https://doi.org/10.18093/0869-0189-2025-35-1-16-41 (in Russian).

5. Sendama W., Funston W., Rostron A.J. et al. Tissue-Resident Memory T Cells Are Implicated in the Pathogenesis of Hypersensitivity Pneumonitis. Am. J. Respir. Crit. Care Med. 2023; 207(9): 1246–1249. https://doi.org/10.1164/rccm.202212-2310LE

6. Raghu G., Remy-Jardin M., Ryerson C.J., Myers J.L., Kreuter M., Vasakova M. all. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 2020; 202(3): e36–e69. https://doi.org/10.1164/rccm.202005-2032ST

7. Watts M.M., Grammer L.C. Hypersensitivity pneumonitis. Allergy Asthma Proc. 2019; 40(6): 425–428. https://doi.org/10.2500/aap.2019.40.4263

8. Article E. Clinical recommendations. Occupational exogenic allergic alveolitis (project). Russian Journal of Occupational Health and Industrial Ecology. 2018; (3): 42–64. https://elibrary.ru/ytghic (in Russian).

9. Churg A. Hypersensitivity pneumonitis: new concepts and classifications. Mod. Pathol. 2022; 35(1): 15–27. https://doi.org/10.1038/s41379-021-00866-y

10. Sforza G.G.R., Marinou A. Hypersensitivity pneumonitis: a complex lung disease. Allergy. 2017; 15: 6. https://doi.org/10.1186/s12948-017-0062-7

11. Chen X., Yang X., Ren Y., Xie B., Xie S., Zhao L. et al. Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes. Chin Med J. 2023; 136(23): 2839–46 https://doi.org/10.1097/CM9.0000000000002613

12. Johannson K.A., Barnes H., Bellanger A.P., et al. Exposure assessment tools for hypersen-sitivity pneumonitis. An Official American Thoracic Society Work-shop Report. Ann. Am. Thorac. Soc. 2020; 17(12): 1501–9. https://doi.org/10.1513/AnnalsATS.202008-942ST

13. Hatim L., Denning D.W. Aspergillus IgG antibody testing in the diagnosis of hypersensitivity pneumonitis: A scoping review. Chronic respiratory disease. 2025; 22: 14799731251326592. https://doi.org/10.1177/14799731251326592

14. Jenkins A.R., Chua A., Chami H., Diaz-Mendoza J., Duggal A., Knight S., Patolia S., Tamae-Kakazu M., Raghu G., Wilson K.C. Questionnaires or Serum Immunoglobulin G Testing in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease. Annals of the American Thoracic Society. 2021; 18(1): 130–147. https://doi.org/10.1513/AnnalsATS.202005-419OC

15. Maher T.M. Interstitial Lung Disease: A Review. JAMA. 2024; 331(19): 1655–1665. https://doi.org/10.1001/jama.2024.3669

16. Barnes H., Corte T.J., Keir G., Khor Y.H., Limaye S., Wrobel J.P., Veitch E., Harrington J., Dowman L., Beckert L., Milne D., De Losa R., Cooper W.A., Bell P.T., Balakrishnan P., Troy L.K. Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand.

17. Respirology (Carlton, Vic.). 2024; 29(12): 1023–1046. https://doi.org/10.1111/resp.14847

18. Samson M.H., Vestergaard J.M., Knudsen C.S., Kolstad H.A. Serum levels of IgG antibodies against Aspergillus fumigatus and the risk of hypersensitivity pneumonitis and other interstitial lung diseases. Scand

19. J. Clin. Lab. Invest. 2021; 81(6): 451–453. https://doi.org/10.1080/00365513.2021.1943758

20. Neklyudova G.V., Chernyak A.V. Clinical significance of studying the diffusing capacity of the lungs. Prakticheskaya pul’monoligiya. 2013; 4 (in Russian).